IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p
Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor...
Saved in:
Published in | Breast cancer research : BCR Vol. 20; no. 1; pp. 32 - 15 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.04.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype.
RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells.
In breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs.
Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. |
---|---|
AbstractList | Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype.
RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells.
In breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs.
Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. Abstract Background Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype. Methods RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells. Results In breast cancer cells, IMP1 interacts with UCA1 via the “ACACCC” motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs. Conclusions Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. Background Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype. Methods RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells. Results In breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs. Conclusions Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. Keywords: lncRNA, RNA-binding protein, IMP1, UCA1, IMP1-UCA1 interaction, UCA1-miR122-5p interaction Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype.BACKGROUNDLong noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype.RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells.METHODSRT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells.In breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs.RESULTSIn breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs.Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness.CONCLUSIONSOur study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the interaction with RNA-binding proteins and micro RNAs (miRNAs). Here, we report that in breast carcinoma cells, the insulin-like growth factor 2 messenger RNA binding protein (IMP1) binds to lncRNA urethral carcinoma-associated 1 (UCA1) and suppresses the UCA1-induced invasive phenotype. RT-qPCR and RNA sequence assays were used to investigate the expression of UCA1 and miRNAs in breast cancer cells in response to IMP1 expression. The role of IMP1-UCA1 interaction in cell invasion was demonstrated by transwell analysis through loss-of-function and gain-of-function effects. RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions of IMP1-UCA1 and UCA1-miR-122-5p involved in breast cancer cells. In breast cancer cells, IMP1 interacts with UCA1 via the "ACACCC" motifs within UCA1 and destabilizes UCA1 through the recruitment of CCR4-NOT1 deadenylase complex. Meanwhile, binding of IMP1 prevents the association of miR-122-5p with UCA1, thereby shifting the availability of miR-122-5p from UCA1 to the target mRNAs and reducing the UCA1-mediated cell invasion. Accordingly, either IMP1 silencing or UCA1 overexpression resulted in reduced levels of free miR-122-5p within the cytoplasm, affecting miR-122-5p in regulating its target mRNAs. Our study provides initial evidence that interaction between IMP1 and UCA1 enhances UCA1 decay and competes for miR-122-5p binding, leading to the liberation of miR-122-5p activity and the reduction of cell invasiveness. |
ArticleNumber | 32 |
Audience | Academic |
Author | Meng, Xiuhua Gu, Wei Singer, Robert Zhou, Yanchun Li, Wei Li, Delin Chen, Shaoying |
Author_xml | – sequence: 1 givenname: Yanchun surname: Zhou fullname: Zhou, Yanchun – sequence: 2 givenname: Xiuhua surname: Meng fullname: Meng, Xiuhua – sequence: 3 givenname: Shaoying surname: Chen fullname: Chen, Shaoying – sequence: 4 givenname: Wei surname: Li fullname: Li, Wei – sequence: 5 givenname: Delin surname: Li fullname: Li, Delin – sequence: 6 givenname: Robert surname: Singer fullname: Singer, Robert – sequence: 7 givenname: Wei surname: Gu fullname: Gu, Wei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29669595$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kkuLFDEUhQsZcR76A9xIwI2bGpN05bURmsZHw4giDrgL6eSmOkN1pU2qBmbrLzfVNSPTooSQm-Q7hzzOeXXSxx6q6iXBl4RI_jaTBWayxqR0xVRNnlRnpOGsZg39cfKoPq3Oc77BmAjJ5LPqlCrOi4CdVb_Wn78SlKAdOzNARterJal34EKZOWSh61Dob00OsUfDNsWx3SJvbOjCYIbQtwcBcmDNHTK9m6oEBS87wxZQ3se-BQTegx1Q9DPuY0K78K0mlNZs_7x66k2X4cX9eFFdf3j_ffWpvvrycb1aXtWWKTnUQnLlnfENJopjLkxDnQBqhHJSOCcIld5RZTeEqg3D0DjKiQcA2XBilFlcVOvZ10Vzo_cp7Ey609EEfViIqdUmDcF2oIFR55y3innVgFxsQDhJ2GLjmJPY4uL1bvbaj5vyWhb6IZnuyPR4pw9b3cZbzRQWDZ8M3twbpPhzhDzoXcjTc5se4pg1xVRwTDGZ0Ncz2ppytND7WBzthOsla7hcNLKRhbr8B1Wag12wJTc-lPUjwavHV_hz9odsFEDMgE0x5wRe28Onx-lGodME6ymFek6hLinUUwo1KUryl_LB_P-a35Fe3Wo |
CitedBy_id | crossref_primary_10_3390_cancers10110440 crossref_primary_10_1186_s12967_021_02872_9 crossref_primary_10_1016_j_isci_2023_107642 crossref_primary_10_1186_s12935_024_03591_z crossref_primary_10_3390_ijms21072549 crossref_primary_10_1007_s13402_023_00806_9 crossref_primary_10_3389_fgene_2022_994003 crossref_primary_10_3892_ijmm_2018_3959 crossref_primary_10_1016_j_critrevonc_2024_104271 crossref_primary_10_3390_cells12040674 crossref_primary_10_3390_genes13071254 crossref_primary_10_1016_j_gendis_2023_06_017 crossref_primary_10_1016_j_ncrna_2022_06_003 crossref_primary_10_1016_j_biopha_2019_109459 crossref_primary_10_1186_s12859_022_04908_3 crossref_primary_10_1007_s10637_021_01148_9 crossref_primary_10_3389_fonc_2021_677111 crossref_primary_10_1111_cpr_12822 crossref_primary_10_1002_jcp_29188 crossref_primary_10_3389_fonc_2022_929037 crossref_primary_10_3892_etm_2019_7526 crossref_primary_10_1016_j_bbrc_2018_05_104 crossref_primary_10_1016_j_scitotenv_2022_158918 crossref_primary_10_1002_1878_0261_13045 crossref_primary_10_1186_s12943_020_01181_x crossref_primary_10_3390_ijms242115600 crossref_primary_10_3390_ijms252111565 crossref_primary_10_1038_s41389_019_0182_7 crossref_primary_10_1002_jcp_30699 crossref_primary_10_3389_fgstr_2022_969533 crossref_primary_10_1124_molpharm_122_000530 crossref_primary_10_3892_mmr_2024_13217 crossref_primary_10_1002_cam4_3344 crossref_primary_10_3390_ijms21051564 crossref_primary_10_1016_j_ncrna_2024_01_019 crossref_primary_10_3892_mmr_2022_12591 crossref_primary_10_1016_j_neo_2021_04_002 crossref_primary_10_3390_cimb46030174 crossref_primary_10_1002_1873_3468_13470 crossref_primary_10_3892_etm_2019_8152 crossref_primary_10_3892_etm_2019_7564 crossref_primary_10_1080_21691401_2019_1652630 crossref_primary_10_3390_cancers12092406 crossref_primary_10_1186_s40364_021_00295_8 |
Cites_doi | 10.1016/S0092-8674(03)00759-1 10.1007/s11427-013-4553-6 10.1101/gad.177428.111 10.1074/jbc.M409070200 10.1042/BC20070090 10.1038/nature04115 10.1042/BC20040151 10.1126/science.1138341 10.1186/1476-4598-13-92 10.1016/j.cell.2011.09.028 10.1016/j.tig.2013.01.004 10.18632/oncotarget.3219 10.1002/hep.22806 10.1042/BC20040063 10.1101/gad.1324305 10.1128/MCB.17.4.2158 10.1038/nature08975 10.18632/oncotarget.7464 10.1093/bib/bbv031 10.1093/bfgp/elq028 10.1038/srep23892 10.1002/hep.26537 10.1016/j.cell.2011.07.014 10.1016/j.cell.2009.01.035 10.1158/1078-0432.CCR-06-0134 10.1042/BST20120074 10.1038/nature12785 10.1038/cgt.2013.82 10.1242/jcs.086132 10.3727/096504017X14934860122864 10.1038/nature02871 10.1093/nar/gkq1003 10.1038/nrg2521 10.1038/nrg3074 10.1038/nature07672 10.1016/j.tig.2015.03.007 10.1101/gad.1862910 10.1038/nrg2673 10.1038/ncomms4596 10.1242/jcs.045278 10.1038/ng.848 10.1016/j.febslet.2008.05.012 10.1038/nm1784 10.1242/jcs.161679 10.1038/nature06992 10.1007/s13277-015-4090-y 10.1038/nature12986 10.1172/JCI63539 10.1016/j.tig.2008.05.004 10.1038/cddis.2013.541 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 BioMed Central Ltd. The Author(s). 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: The Author(s). 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/s13058-018-0959-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1465-542X |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_e52dddfc95f94e83be7d8153bd5d80c0 PMC5907460 A546834848 29669595 10_1186_s13058_018_0959_1 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GroupedDBID | --- 04C 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACJQM ACMJI ACPRK ADBBV ADFRT ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BMSDO BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EIHBH EJD F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO ICW IHR INH INR ITC KQ8 O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ ROL RPM RSV SBL SOJ TR2 U2A UKHRP WOQ 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c598t-7869fdaf40196067a42d7e2a79d87dd7128fd29cb129b50e4d261feee8461a9a3 |
IEDL.DBID | DOA |
ISSN | 1465-542X 1465-5411 |
IngestDate | Wed Aug 27 01:20:32 EDT 2025 Thu Aug 21 14:15:26 EDT 2025 Fri Jul 11 08:12:03 EDT 2025 Tue Jun 17 21:20:51 EDT 2025 Tue Jun 10 20:27:56 EDT 2025 Thu Jan 02 22:57:48 EST 2025 Tue Jul 01 02:43:11 EDT 2025 Thu Apr 24 22:53:31 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | IMP1-UCA1 interaction UCA1 RNA-binding protein lncRNA UCA1-miR122-5p interaction IMP1 |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c598t-7869fdaf40196067a42d7e2a79d87dd7128fd29cb129b50e4d261feee8461a9a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/e52dddfc95f94e83be7d8153bd5d80c0 |
PMID | 29669595 |
PQID | 2027602010 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e52dddfc95f94e83be7d8153bd5d80c0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5907460 proquest_miscellaneous_2027602010 gale_infotracmisc_A546834848 gale_infotracacademiconefile_A546834848 pubmed_primary_29669595 crossref_citationtrail_10_1186_s13058_018_0959_1 crossref_primary_10_1186_s13058_018_0959_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-18 |
PublicationDateYYYYMMDD | 2018-04-18 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Breast cancer research : BCR |
PublicationTitleAlternate | Breast Cancer Res |
PublicationYear | 2018 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | T Song (959_CR38) 2015; 128 E Bernstein (959_CR27) 2005; 19 T Hung (959_CR10) 2011; 43 G St Laurent (959_CR3) 2015; 31 J Condeelis (959_CR31) 2005; 97 G Wang (959_CR35) 2016; 7 TR Mercer (959_CR4) 2009; 10 Z Bian (959_CR18) 2016; 6 W Gu (959_CR36) 2012; 125 PK Goudarzi (959_CR44) 2016; 37 M Cesana (959_CR13) 2011; 147 M Esteller (959_CR19) 2011; 12 X Wang (959_CR25) 2008; 454 W Gu (959_CR37) 2009; 122 K Wang (959_CR49) 2014; 5 S Huttelmaier (959_CR32) 2005; 438 JA Chao (959_CR40) 2010; 24 M Guttman (959_CR2) 2009; 458 F Ferre (959_CR21) 2016; 17 MS Kumar (959_CR12) 2014; 505 DD Licatalosi (959_CR24) 2010; 11 V Ambros (959_CR46) 2004; 431 F Wang (959_CR50) 2008; 582 A Castello (959_CR8) 2013; 29 MA Faghihi (959_CR11) 2008; 14 AF Ross (959_CR34) 1997; 17 XS Wang (959_CR39) 2006; 12 Y Tay (959_CR48) 2014; 505 L Jeffery (959_CR26) 2004; 279 X Han (959_CR43) 2014; 21 RA Gupta (959_CR9) 2010; 464 C Barrandon (959_CR28) 2008; 100 959_CR51 VL Patel (959_CR33) 2012; 26 Z Jeyapalan (959_CR47) 2011; 39 S Kishore (959_CR23) 2010; 9 KE Lukong (959_CR7) 2008; 24 RW Carthew (959_CR6) 2009; 136 M Hammerle (959_CR29) 2013; 58 J Huang (959_CR15) 2014; 5 CL Bartels (959_CR5) 2009; 1 SH Hsu (959_CR53) 2012; 122 F Wang (959_CR16) 2015; 6 R Doidge (959_CR41) 2012; 40 J Zhu (959_CR22) 2013; 56 M Rao (959_CR52) 2017; 7 WC Tsai (959_CR42) 2009; 49 L Salmena (959_CR14) 2011; 146 YL Tuo (959_CR17) 2015; 19 JK Yisraeli (959_CR30) 2005; 97 DS Schwarz (959_CR45) 2003; 115 XH Liu (959_CR20) 2014; 13 P Kapranov (959_CR1) 2007; 316 |
References_xml | – volume: 115 start-page: 199 issue: 2 year: 2003 ident: 959_CR45 publication-title: Cell doi: 10.1016/S0092-8674(03)00759-1 – volume: 56 start-page: 876 issue: 10 year: 2013 ident: 959_CR22 publication-title: Sci China Life Sci doi: 10.1007/s11427-013-4553-6 – volume: 26 start-page: 43 issue: 1 year: 2012 ident: 959_CR33 publication-title: Genes Dev doi: 10.1101/gad.177428.111 – volume: 279 start-page: 49479 issue: 47 year: 2004 ident: 959_CR26 publication-title: J Biol Chem doi: 10.1074/jbc.M409070200 – volume: 100 start-page: 83 issue: 2 year: 2008 ident: 959_CR28 publication-title: Biol Cell doi: 10.1042/BC20070090 – volume: 438 start-page: 512 issue: 7067 year: 2005 ident: 959_CR32 publication-title: Nature doi: 10.1038/nature04115 – volume: 97 start-page: 87 issue: 1 year: 2005 ident: 959_CR30 publication-title: Biol Cell doi: 10.1042/BC20040151 – volume: 316 start-page: 1484 issue: 5830 year: 2007 ident: 959_CR1 publication-title: Science doi: 10.1126/science.1138341 – volume: 13 start-page: 92 year: 2014 ident: 959_CR20 publication-title: Mol Cancer doi: 10.1186/1476-4598-13-92 – volume: 147 start-page: 358 issue: 2 year: 2011 ident: 959_CR13 publication-title: Cell doi: 10.1016/j.cell.2011.09.028 – volume: 19 start-page: 3403 issue: 18 year: 2015 ident: 959_CR17 publication-title: Eur Rev Med Pharmacol Sci – volume: 29 start-page: 318 issue: 5 year: 2013 ident: 959_CR8 publication-title: Trends Genet doi: 10.1016/j.tig.2013.01.004 – volume: 6 start-page: 7899 issue: 10 year: 2015 ident: 959_CR16 publication-title: Oncotarget doi: 10.18632/oncotarget.3219 – volume: 49 start-page: 1571 issue: 5 year: 2009 ident: 959_CR42 publication-title: Hepatology doi: 10.1002/hep.22806 – volume: 97 start-page: 97 issue: 1 year: 2005 ident: 959_CR31 publication-title: Biol Cell doi: 10.1042/BC20040063 – volume: 19 start-page: 1635 issue: 14 year: 2005 ident: 959_CR27 publication-title: Genes Dev doi: 10.1101/gad.1324305 – volume: 17 start-page: 2158 issue: 4 year: 1997 ident: 959_CR34 publication-title: Mol Cell Biol doi: 10.1128/MCB.17.4.2158 – volume: 7 start-page: 323 issue: 2 year: 2017 ident: 959_CR52 publication-title: Am J Cancer Res – volume: 464 start-page: 1071 issue: 7291 year: 2010 ident: 959_CR9 publication-title: Nature doi: 10.1038/nature08975 – volume: 7 start-page: 15690 issue: 13 year: 2016 ident: 959_CR35 publication-title: Oncotarget doi: 10.18632/oncotarget.7464 – volume: 17 start-page: 106 issue: 1 year: 2016 ident: 959_CR21 publication-title: Brief Bioinform doi: 10.1093/bib/bbv031 – volume: 9 start-page: 391 issue: 5–6 year: 2010 ident: 959_CR23 publication-title: Brief funct Genom doi: 10.1093/bfgp/elq028 – volume: 6 start-page: 23892 year: 2016 ident: 959_CR18 publication-title: Sci Rep doi: 10.1038/srep23892 – volume: 58 start-page: 1703 issue: 5 year: 2013 ident: 959_CR29 publication-title: Hepatology doi: 10.1002/hep.26537 – volume: 146 start-page: 353 issue: 3 year: 2011 ident: 959_CR14 publication-title: Cell doi: 10.1016/j.cell.2011.07.014 – volume: 136 start-page: 642 issue: 4 year: 2009 ident: 959_CR6 publication-title: Cell doi: 10.1016/j.cell.2009.01.035 – volume: 12 start-page: 4851 issue: 16 year: 2006 ident: 959_CR39 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0134 – volume: 40 start-page: 896 issue: 4 year: 2012 ident: 959_CR41 publication-title: Biochem Soc Trans doi: 10.1042/BST20120074 – volume: 1 start-page: 406 issue: 4 year: 2009 ident: 959_CR5 publication-title: Am J Transl Res – volume: 505 start-page: 212 issue: 7482 year: 2014 ident: 959_CR12 publication-title: Nature doi: 10.1038/nature12785 – volume: 21 start-page: 60 issue: 2 year: 2014 ident: 959_CR43 publication-title: Cancer Gene Ther doi: 10.1038/cgt.2013.82 – volume: 125 start-page: 81 issue: Pt 1 year: 2012 ident: 959_CR36 publication-title: J Cell Sci doi: 10.1242/jcs.086132 – ident: 959_CR51 doi: 10.3727/096504017X14934860122864 – volume: 431 start-page: 350 issue: 7006 year: 2004 ident: 959_CR46 publication-title: Nature doi: 10.1038/nature02871 – volume: 39 start-page: 3026 issue: 8 year: 2011 ident: 959_CR47 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq1003 – volume: 10 start-page: 155 issue: 3 year: 2009 ident: 959_CR4 publication-title: Nat Rev Genet doi: 10.1038/nrg2521 – volume: 12 start-page: 861 issue: 12 year: 2011 ident: 959_CR19 publication-title: Nat Rev Genet doi: 10.1038/nrg3074 – volume: 458 start-page: 223 issue: 7235 year: 2009 ident: 959_CR2 publication-title: Nature doi: 10.1038/nature07672 – volume: 31 start-page: 239 issue: 5 year: 2015 ident: 959_CR3 publication-title: Trends Genet doi: 10.1016/j.tig.2015.03.007 – volume: 24 start-page: 148 issue: 2 year: 2010 ident: 959_CR40 publication-title: Genes Dev doi: 10.1101/gad.1862910 – volume: 11 start-page: 75 issue: 1 year: 2010 ident: 959_CR24 publication-title: Nat Rev Genet doi: 10.1038/nrg2673 – volume: 5 start-page: 3596 year: 2014 ident: 959_CR49 publication-title: Nat Commun doi: 10.1038/ncomms4596 – volume: 122 start-page: 1895 issue: Pt 11 year: 2009 ident: 959_CR37 publication-title: J Cell Sci doi: 10.1242/jcs.045278 – volume: 43 start-page: 621 issue: 7 year: 2011 ident: 959_CR10 publication-title: Nat Genet doi: 10.1038/ng.848 – volume: 582 start-page: 1919 issue: 13 year: 2008 ident: 959_CR50 publication-title: FEBS Lett doi: 10.1016/j.febslet.2008.05.012 – volume: 14 start-page: 723 issue: 7 year: 2008 ident: 959_CR11 publication-title: Nat Med doi: 10.1038/nm1784 – volume: 128 start-page: 1001 issue: 5 year: 2015 ident: 959_CR38 publication-title: J Cell Sci doi: 10.1242/jcs.161679 – volume: 454 start-page: 126 issue: 7200 year: 2008 ident: 959_CR25 publication-title: Nature doi: 10.1038/nature06992 – volume: 37 start-page: 5775 issue: 5 year: 2016 ident: 959_CR44 publication-title: Tumour Biol doi: 10.1007/s13277-015-4090-y – volume: 505 start-page: 344 issue: 7483 year: 2014 ident: 959_CR48 publication-title: Nature doi: 10.1038/nature12986 – volume: 122 start-page: 2871 issue: 8 year: 2012 ident: 959_CR53 publication-title: J Clin Invest doi: 10.1172/JCI63539 – volume: 24 start-page: 416 issue: 8 year: 2008 ident: 959_CR7 publication-title: Trends Genet doi: 10.1016/j.tig.2008.05.004 – volume: 5 start-page: e1008 year: 2014 ident: 959_CR15 publication-title: Cell Death Dis doi: 10.1038/cddis.2013.541 |
SSID | ssj0017858 |
Score | 2.4465997 |
Snippet | Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression through the... Background Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene expression... Abstract Background Long noncoding RNAs (LncRNAs) represent a class of widespread and diverse endogenous RNAs that can posttranscriptionally regulate gene... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 32 |
SubjectTerms | Analysis Binding proteins Breast Neoplasms - genetics Cell Line, Tumor Cell Movement - genetics Cell Proliferation - genetics Epithelial-Mesenchymal Transition - genetics Female Gene Expression Regulation, Neoplastic Humans IMP1 IMP1-UCA1 interaction Insulin-like growth factor I lncRNA MicroRNA MicroRNAs - genetics Neoplasm Invasiveness - genetics Neoplasm Invasiveness - pathology RNA sequencing RNA, Long Noncoding - genetics RNA-binding protein RNA-Binding Proteins - genetics UCA1 UCA1-miR122-5p interaction |
Title | IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29669595 https://www.proquest.com/docview/2027602010 https://pubmed.ncbi.nlm.nih.gov/PMC5907460 https://doaj.org/article/e52dddfc95f94e83be7d8153bd5d80c0 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdbB2MvY2v34a0LGowNBqK2I1nSY1JaukFKCQuEvQhZktvA6pQmHfR1f_nuZCXEDLaXvQQTyVjy3fl-96E7Qj5YEKC8wqNbgAUY184z5WzJcstzDvBbKI2nkSfn1dmMf52L-U6rL8wJ68oDdy_uKIjSe984LRrNgxrWQXoFYlp74VXuorUOOm9jTKX4gYSHpBhmoaqjFXypBSZtYahfaFb0tFAs1v_nJ3lHJ_XzJXcU0Okz8jQhRzrqVvycPAjtPjkYtWA1X9_TjzTmckYn-T55PEkh8wPy68vkoqC3Xcv5sKKz41HB4nkRwJoU_fZ00f606DSjqWkPbaxLxbvby3gD9cHZe2pbj1eYx44jgB0pZtheBtqlhdBl000HJEyvF1NWoA1684LMTk--HZ-x1HiBOaHVmklV6cbbhmPxHFBnlpdehtJK7ZX0XoJOa3ypXQ1goRZ54B7ssCaEAGCmsNoOX5K9dtmG14Ra4QCCSoz1OM7RjYcYSVTcNxbAm8xIviGEcakqOTbH-GGidaIq09HOAO0M0s4UGfm8veWmK8nxt8ljpO52IlbTjn8Aj5nEY-ZfPJaRT8gbBmUeFudsOroAW8TqWWYkeKWGXHGVkcPeTJBV1xt-v-Eug0OY4NaG5d3KoA-qyjE1ISOvOm7brrkEkxQ2IzIie3zY21R_pF1cxVLhAn0fVf7mf7yFt-RJGSWIs0Idkr317V14B4hsXQ_IQzmXA_JofHJ-MR1EUYTf6fj7b1rIM-k |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IMP1+regulates+UCA1-mediated+cell+invasion+through+facilitating+UCA1+decay+and+decreasing+the+sponge+effect+of+UCA1+for+miR-122-5p&rft.jtitle=Breast+cancer+research+%3A+BCR&rft.au=Yanchun+Zhou&rft.au=Xiuhua+Meng&rft.au=Shaoying+Chen&rft.au=Wei+Li&rft.date=2018-04-18&rft.pub=BMC&rft.eissn=1465-542X&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs13058-018-0959-1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e52dddfc95f94e83be7d8153bd5d80c0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-542X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-542X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-542X&client=summon |